SCHEMBL265937

SCHEMBL265937

CC(=O)c1ccc(N)c(N)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.62
CREBBP Q92793 1/20 0.56
MAPT P10636 6/20 0.48
TDP1 Q9NUW8 1/20 0.48
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
CYP2A6 P11509 1/20 0.45
ALDH1A1 P00352 3/20 0.44
MAPK1 P28482 2/20 0.44
LMNA P02545 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GAA P10253 2/20 0.44
PKM P14618 1/20 0.44
HTT P42858 1/20 0.44
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
HPGD P15428 3/20 0.43
KMT2A Q03164 1/20 0.43
HDAC2 Q92769 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31495791 1.00 PRKCI (0.62) PRKCICREBBPMAPTTDP1RAB9A
SCHEMBL30508415 0.82 PRKCI (0.53) PRKCICREBBPMAPTTDP1RAB9A
SCHEMBL30311575 0.82 PRKCI (0.53) PRKCICREBBPMAPTTDP1RAB9A
SCHEMBL1026788 0.82 PRKCI (0.53) PRKCICREBBPMAPTTDP1RAB9A
SCHEMBL3287715 0.82 PRKCI (0.58) PRKCICREBBPMAPTTDP1RAB9A
SCHEMBL30527097 0.82 PRKCI (0.58) PRKCICREBBPMAPTTDP1RAB9A
SCHEMBL31208309 0.82 PRKCI (0.53) PRKCICREBBPMAPTRAB9ANPC1
SCHEMBL12045429 0.82 PRKCI (0.58) PRKCICREBBPMAPTTDP1RAB9A
SCHEMBL20110922 0.82 PRKCI (0.53) PRKCICREBBPMAPTTDP1RAB9A
SCHEMBL571550 0.82 MAPT (0.73) PRKCICREBBPMAPTTDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119499250-B Pyruvate composition for regenerating and repairing lung tissue and preparation method thereof 江苏长泰药业股份有限公司 2025-04-18 CN claimed
CN-119499250-A Pyruvate composition for regenerating and repairing lung tissue and preparation method thereof 江苏长泰药业股份有限公司 2025-02-25 CN claimed
CN-116102440-A Preparation method of 1- (3, 4-diaminophenyl) ethanone 上海琼燕医药科技有限公司 2023-05-12 CN claimed
EP-1828210-A1 CHEMICAL COMPOSITIONS FOR AUTHENTICATABLE POLYMERS AND ARTICLES, AND AUTHENTICATION METHODS THEREOF General Electric Company (US) 2007-09-05 EP claimed
US-7230113-B2 Chemical compositions for authenticatable polymers and articles, and authentication methods thereof GENERAL ELECTRIC COMPANY (US) 2007-06-12 US claimed
WO-2006065541-A1 CHEMICAL COMPOSITIONS FOR AUTHENTICATABLE POLYMERS AND ARTICLES, AND AUTHENTICATION METHODS THEREOF GENERAL ELECTRIC COMPANY (US) 2006-06-22 WO claimed
US-20060135658-A1 Chemical compositions for authenticatable polymers and articles, and authentication methods thereof SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2006-06-22 US claimed
CN-116102440-B Preparation method of 1- (3, 4-diaminophenyl) ethanone 上海琼燕医药科技有限公司 2026-04-03 CN disclosed
CN-116102440-B Preparation method of 1- (3, 4-diaminophenyl) ethanone 上海琼燕医药科技有限公司 2026-04-03 CN disclosed
CN-119899130-A Preparation method of 4-aminobenzonitrile and polyimide thereof 辽宁兴福新材料股份有限公司 2025-04-29 CN disclosed
CN-119499250-B Pyruvate composition for regenerating and repairing lung tissue and preparation method thereof 江苏长泰药业股份有限公司 2025-04-18 CN disclosed
CN-119499250-A Pyruvate composition for regenerating and repairing lung tissue and preparation method thereof 江苏长泰药业股份有限公司 2025-02-25 CN disclosed
CN-116348109-B Piperazine derivative, and preparation method and application thereof 浙江海正药业股份有限公司 2025-01-21 CN disclosed
EP-0209707-A2 2-Aryl imidazoles, pharmaceutical compositions containing them and process for their preparation Dr. Karl Thomae GmbH (DE) 1987-01-28 EP disclosed
EP-0172631-A1 Therapeutic agents The Boots Company PLC (GB) 1986-02-26 EP disclosed
US-4363761-A DYEING CELLULOSE AND LEATHER; TEXTILES; PAPERMAKING SANDOZ LTD. (CH) 1982-12-14 US disclosed
US-4273707-A Monoazo and disazo dyes containing at least one sulfo group and at least two basic or cationic groups SANDOZ LTD. (CH) 1981-06-16 US disclosed
US-4268439-A Basic azo dyestuffs having benzylammoniumamine substituent in the coupling component BAYER AKTIENGESELLSCHAFT (DE) 1981-05-19 US disclosed
US-4167569-A ANTICOAGULANTS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1979-09-11 US disclosed
US-4138568-A NITRO-O-PHENYLENEDIAMINE, UREA, HALOBENZENE SOLVENT CIBA-GEIGY CORPORATION (US) 1979-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135658-A1 Chemical compositions for authenticatable polymers and articles, and authentication methods thereof H1-4, BICRA, PBRM1 PRKCI 2700/4885CREBBP 1249/4885MAPT 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.